CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Day 2026
    • Funding of the CTGCT
  • Job Openings
  • Products and Services
  • Learning Box
    • Learning Box
    • CTGCT Science Talks
    • Publications
    • CTGCT Days 2025
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Pacients

  • Articles
  • Pacients
  • Gen Therapy
  • Research
  • CTGCT
  • Rodrigo Ortiz
8 October 2026

The Growing Impact of Optogenetics

What if scientists could control the activity of cells using nothing more than pulses of light? What sounds like science fiction has become one of the most influential technologies in modern biology. Earlier this ...

Gemini Generated Image 3345lz3345lz3345
  • Events
  • Pacients
  • ATMPs
  • Clinic study
  • Economics
  • Investment
  • Marketaccess
  • CTGCT
  • Gregor Cuzak
29 September 2026

CTGCT at the Caring for Rare 2026 Conference: In Rare Diseases, Research, Clinical Practice and Patients Need a Shared Space

A representative of CTGCT – the Centre of Excellence for Technologies of Gene and Cell Therapy, Gregor Cuzak, attended the 7th regional Caring for Rare 2026 conference in Belgrade on 3 and 4 September, ...

Panel Foto
  • Articles
  • Pacients
  • Cell therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
16 September 2026

From Skin Cells to Stem Cells: Reprogramming Cells to Study Disease

Every cell in the human body contains essentially the same genetic instructions, yet a heart cell behaves very differently from a nerve or skin cell. For many years, scientists assumed that once a cell ...

Darja Marolt CTGCT Best workshop
  • Articles
  • Pacients
  • Gen Therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
10 September 2026

Living Medicines: The Promise and Challenges of CAR-T Therapy

Cancer treatment has undergone a remarkable transformation over the past decade. What if, instead of relying solely on drugs to attack tumors, we could reprogram a patient's own immune cells to seek out and ...

Tina Fink Best Ljubljana
  • Articles
  • Pacients
  • Gen Therapy
  • Research
  • CTGCT
  • Rodrigo Ortiz
27 August 2026

The Delivery Challenge of Genome Editing with CRISPR

CRISPR technologies can rewrite a disease-causing DNA sequence, switch a gene off, correct a single genetic letter or even alter gene activity without changing the underlying DNA. Yet a genome editor can only work ...

Header of the paper In vivo delivery strategies for therapeutic CRISPR genome editing
  • Interview
  • Pacients
  • ATMPs
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
24 July 2026

Duško Lainšček interviewed by Svet24

How does a breakthrough gene therapy begin? What does it take to turn a scientific idea into a treatment that can reach a patient? In this interview, Duško Lainšček, researcher at the Institute of Chemistry ...

Dusko Interview
  • Events
  • Pacients
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Drug Discovery
  • CTGCT
  • NIC
  • Gregor Cuzak
23 June 2026 Event Date: 12 June 2026 do: 12 June 2026 •

CTGCT and the National Institute of Chemistry presented gene and cell therapies to students of Gimnazija Jesenice.

On 12 June 2026, representatives of the National Institute of Chemistry and CTGCT visited Gimnazija Jesenice, where they presented modern biological medicines and the development of gene and cell therapies to third-year students.

Gimnazija Jesenice
  • Articles
  • Pacients
  • ATMPs
  • CTGCT
  • Rodrigo Ortiz
19 June 2026

CTGCT Newsletter No. 4

Just as the summer is about to start your friend and colleague the CTGCT is publishing its latest newsletter with news and future events. Watch out! This is becoming a tradition every 6 months ...

CTGCT Day 2026 announcement
  • Events
  • Pacients
  • CTGCT
  • NIC
  • Rodrigo Ortiz
22 May 2026 Event Date: 13 May 2026 do: 13 May 2026 •

CTGCT at BioFair 5.0: connecting with the next generation of experts in gene and cell therapy

On the 13th of May, part of the CTGCT team attended BioFair 5.0 the largest career event for students in the field of life sciences in Slovenia, organized by the non-profit student association BEST ...

Img 20260513 093213
  • Articles
  • Pacients
  • ATMPs
  • Pre Clinical
  • Research
  • CTGCT
  • UCL
  • Rodrigo Ortiz
11 May 2026

Next-Generation T-Cell Therapies: From Laboratory Engineering to In Vivo Programming

In our latest edition of the CTGCT Science Talks webinar series we had Dr. Thomas Fox, a clinician-scientist whose work bridges the gap between the clinical-laboratory interface working across Harvard Medical School and the ...

Tom Fox 1
  • Events
  • Pacients
  • ATMPs
  • Research
  • CTGCT
  • UCL
  • Rodrigo Ortiz
5 May 2026 Event Date: 22 April 2026 do: 22 April 2026 •

CTGCT visit to UCL and attending the UCL Advanced Therapies Symposium 2026

Last week 3 of our colleagues (Tjaša, Mojca and Tina) attended the UCL Advanced Therapies Symposium 2026 in London, an event dedicated to recent developments in cell and gene therapies and to strengthening links ...

Img 8164 (1)
  • Articles
  • Clinicians
  • Pacients
  • Research
25 March 2026 Event Date: 2 March 2026 • 14:00 do: 2 March 2026 • 14:30

How AI is Helping Us Design the Proteins of the Future

Imagine if we could design the "building blocks" of life just like we design a new house or a car. Instead of relying on what nature has given us through millions of years of ...

Posts pagination

1 2 3 … 5

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ifeelslovenia Logo 400

Project: 101059842 – CTGCT – HORIZON-WIDERA-
Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and European Regional Development Fund EU under Slovenia’s Cohesion Policy Programme 2021-2027 (grant agreement No. C3360-25-952005) and the UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them.


CTGCT © 2026
Website production: Kreativna tovarna